Trio Pharma ApSActive
Key figures
-6.630 kr.+98,4%
Gross profit 2025/26
Key ratios
2025/26-217,6%
Equity ratio
15×
Current ratio
Balance sheet structure
Current assetsNon-current assetsLiabilities and provisionsEquity
Financial statements2025–2026
| 2024/25 | 2025/26 | |
|---|---|---|
| Balance sheet — assets | ||
| Cash and cash equivalents | 164.006 | 229.980 |
| Total current assets | 1.483.837 | 1.394.725 |
| Total non-current assets | 5.973 | 14.075 |
| Total assets | 1.489.810 | 1.408.800 |
| Balance sheet — liabilities and equity | ||
| Current liabilities | 59.077 | 92.705 |
| Non-current liabilities | 4.024.266 | 4.381.111 |
| Total liabilities | 4.083.343 | 4.473.816 |
| Share capital | 50.000 | 50.000 |
| Retained earnings of previous periods | -2.643.533 | -3.115.016 |
| Profit for the year | -1.170.880 | -471.483 |
| Total equity | -2.593.533 | -3.065.016 |
| Income statement | ||
| Gross profit | -411.555 | -6.630 |
| Operating profit | -1.097.889 | -547.329 |
| Profit before income tax | -1.171.743 | -642.061 |
| Profit for the reporting year | -1.170.880 | -471.483 |
| Labour costs | 686.334 | 540.699 |
| Depreciation of non-current assets | — | — |
| Other indicators | ||
| Employees | 2 | 1 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
About the company
Annual report 2026Selskabets formål er at producere, markedsføre, sælge og distribuere naturlægemidler og kosttilskud samt anden hermed beslægtet virksomhed.
Excerpt from the management's review in the latest annual report.